Paracetamol in Patent Ductus Arteriosus
Efficacy and Safety of Paracetamol in Comparison to Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants: A Randomized, Open Label, Comparator-controlled, Prospective Study
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A
A PHASE2 clinical study on Ductus Arteriosus, Patent, this trial is completed. The trial is conducted by Aziende Chimiche Riunite Angelini Francesco S.p.A and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jul 2018 — Aug 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aziende Chimiche Riunite Angelini Francesco S.p.A
For direct contact, visit the study record on ClinicalTrials.gov .